Amy Schumer & Chris Fischer have ended their marriage after seven years
I’ve been so disengaged from Amy Schumer’s comings and goings in recent years. Do I even need to do a recap? She got married to Chris Fischer in February 2018. They welcomed their son Gene in May 2019. Early in their marriage, Chris was diagnosed with autism spectrum disorder. Since becoming a mom, Amy has […]
2 Predictions for Novo Nordisk in 2026
Key Points Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that the company’s pipeline candidates will see strong progress in 2026. Novo Nordisk’s shares appear attractive, despite the challenges it faces. 10 stocks we like better than Novo Nordisk › The past 18 months have […]
Stop Trying to Make the Humanities ‘Relevant’
Humanities departments seem to be in perpetual crisis. Fewer students are enrolling in them. The Trump administration is cutting their funding. Smartphones and social media are hastening the collapse of reading and attention spans, even among students at elite schools. Americans are becoming more skeptical about the economic value of any four-year degree, let alone […]
52 Surprising Things / Watchable American history / See yourself as a verb
52 Surprising Things Every December, writer Tom Whitwell publishes an eclectic list of 52 surprising things Whitwell learned over the year. It’s one of my favorite year-end reads. A few samples: Marchetti’s Constant is the idea that throughout human history, from cave dwellers to ancient Greeks to 21st century Londoners, people tend to commute for […]
Chonky Kitties Beware: Ozempic for Cats Is on the Way
If your cat has reached a size best described as “majestically chonky,” science may soon have a solution that spares you from micromanaging every scoop. A weight-loss drug for cats, modeled after human medications like Ozempic, is now being tested in veterinary clinical trials. More than half of pet cats worldwide are estimated to be […]
Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy—a phase 2 randomized trial
Nature Communications, Published online: 14 December 2025; doi:10.1038/s41467-025-66167-z Semaglutide, a GLP-1 receptor agonist, may offer neuroprotective benefits after stroke, but its effects in large vessel occlusion (LVO) are unknown. Here the authors show, in a phase 2 randomized trial, that semaglutide is safe after endovascular therapy and may improve recovery in patients not receiving intravenous […]
India’s anti-obesity market: generics may lift volumes, raise dropout risk
India’s GLP-1 market may see a surge in volumes but slower value growth as semaglutide goes off patent in March 2026, bringing cheaper generics and intensifying competition
COMMENTARY: The real story behind Trump’s GLP-1 price cut: Markets still rule
Price controls sap resources and ingenuity from America’s pharmaceutical sector
When is it Worth Working?
Published on December 13, 2025 9:40 PM GMT tl;dr: How does an agent decide whether it is worth doing work to get something, as opposed to not working and not getting it? I’m a neuroscientist and my lab did an experiment to explore this question. Rats did voluntary work to earn water in a closed economy, […]
How Were GLP-1 Drugs and Bone Health Linked?
(MedPage Today) — You passed medical training, now see if you can pass our weekly quiz